CD8A and melanoma: Furthermore, the number of CD4+ and CD8+ T cells was pointedly augmented in the treated tumor‐bearing BALB/c mice.[162] It has been revealed that following systemic administration of oncolytic virus M1, the number of infiltrated Tregs in the TME was increased in melanoma and prostatic tumor models.